SARS-CoV-2

Current antiviral treatment course is inadequate for high-risk COVID-19

Molnupiravir's impact on SARS-CoV-2 response in at-risk outpatients.

SARS-CoV-2 variants: How a set of key covariates affect viral kinetics?

A prospective observational cohort study.

Breakthrough RNA mapping method by HIRI researchers

SHIFTR allows unbiased protein identification on RNA regions in live cells.

The complement system damages cells in long-term COVID

Persistent complement dysfunction in long COVID: Inflammation and blood clot risks.

Influenza immunity spurs rapid protection in new vaccine

Influenza boosts antibody power against SARS-CoV-2.

How ultraviolet light degrades coronavirus?

SARS-CoV-2 has among the largest of genomes for RNA viruses.

COVID-19 changes gene activity in olfactory mucosal cells in Alzheimer’s

Distinct immune responses after infection between AD patients and healthy individuals.

SARS-CoV-2 moves within neurons to infect the brain

Separate effects: SARS-CoV-2, neuroinvasion, and anosmia.

COVID-19 vulnerability tied to past infections and vaccination

Mapping antigenic connections in SARS-CoV-2 and serological reactions.

First-ever RNA recovery from extinct species

RNA history of extinct Tasmanian tiger.

COVID patients emit 1,000 virus copies per min in early symptoms

Exhaled SARS-CoV-2 RNA copies during COVID-19 infection.

Recent Stories